View allAll Photos Tagged brainstorming

006

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

3:35 PM

IN DEFENSE OF SCIENCE

We live in a time of mind-boggling change and technological advance. Cars drive themselves. Robots perform surgery. Phones can probe the connections of the universe. And humans edit the molecular instructions that shape their very humanity. Yet even as we hurtle through this futuristic present, swept up in discovery and innovation, a surprisingly powerful force is pushing back from the horizon: the fear of science. That force has rallied to challenge the foundation of science itself, undermining scientific research—and, yes, public health and safety. Now, more than ever, the field requires investment and talent, both of which are imperiled. How can we most effectively respond to this assault? What can be done to restore trust in science and fact? And how can we promote investment in science, and draw a new generation of enterprising thinkers to the field?

Dr. Susan Desmond-Hellmann, Chief Executive Officer, Bill & Melinda Gates Foundation

Dr. Margaret Hamburg, President, American Association for the Advancement of Science

Dr. Lloyd Minor, Carl and Elizabeth Naumann Dean, Stanford University School of Medicine

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

Artiste André Carpin

Photo: ©Dona Moth

047

Tuesday, July 17th, 2018

Fortune Brainstorm Tech

 

7:30–9:30 PM

NYSE Dinner – Aspen Kitchen

 

Photograph by Jordan Curet/Fortune

002

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:05 PM

SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT

The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.

 

The Fortune Brainstorm Health Co-Chairs:

Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health

Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health

Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

037

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

2:25 PM

GUN VIOLENCE AS A PUBLIC HEALTH CRISIS

American students were once again caught in the crosshairs of a school massacre on Valentine’s Day—just after the country witnessed two of its deadliest mass shootings in a 35-day span. Parkland. Las Vegas. Sunderland. Newtown. The painful reminders that the U.S. is the world capital of gun violence keep piling up. Compounding this continuing sorrow is a bitter feud over how to stop it—a fight over firearms that has further polarized the nation. But some health experts say there’s a way to break through this deadly impasse: What if, instead of isolated acts of madness, we treated the ongoing casualties from guns as an epidemic? Here’s how reframing gun violence as an urgent matter of public health might at last lead us to a cure.

 

Dr. Dean Winslow, Professor of Medicine, Stanford University School of Medicine

Dr. Garen Wintemute, Director, Violence Prevention Research Program, UC Davis

Additional speakers to be announced.

Moderator: Michal Lev-Ram, Fortune

 

Photograph by Stuart Isett/Fortune

003

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:20 PM

U.S. HEALTH CARE: AT THE CROSSROADS

A whole lot has changed since Mark Bertolini, back in 2010, took the helm at Aetna, the (now) $63 billion health insurer: The Affordable Care Act, barely then a law, has launched and (kind of) death spiraled. Opioids have become an acknowledged public health enemy. Wellness has become a corporate mantra. Big data, AI, and blockchain, once mere Silicon Valley buzzwords, have become ways of business that health care companies cannot ignore. The whole system has consolidated, while a formidable crew of outsiders—Google, Apple, Amazon—appear poised to disrupt everything. Bertolini has been at the center of it all—in an intimate and candid conversation with Fortune Editor-in-Chief Clifton Leaf, he’ll talk about navigating one of the nation’s largest health insurers (and the 43rd-largest public company in America) through these waters, and about his final act—Aetna’s transformational deal with CVS—and what it means about the future of health care in America.

 

Mark Bertolini, Chairman and CEO, Aetna Inc.

Interviewer: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

017

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

7:45 AM

CONCURRENT BREAKFAST SOLUTION SESSIONS

THE END OF HEALTH CARE PRIVACY… AND IS IT A GOOD THING?

Someone forgot to tell consumers to be careful. Over the past several years, people everywhere have zealously shared their intimate health data with products and services like 23AndMe, FitBit, and the Apple Watch—eager to be guinea pigs in the grand Big Data Experiment of Human Health. But when it comes to the broader medical universe, a matrix of rules and proprietary interests have made discovery from this deep data reservoir restrictive and challenging. Some, likewise, blame the frustrating lack of interoperability in health systems on a misreading of privacy protections—as well as on the unwillingness of private companies to play in the same data sandbox. How do we harness our limitless health-related data while still protecting individual privacy? And here’s a provocative question to start us off: Is privacy all it’s cracked up to be?

 

Anu Acharya, CEO, Mapmygenome

Dr. Kevin Ban, Chief Medical Officer, athenahealth

Colin Hill, Co-Founder, Chairman and CEO, GNS Healthcare

Chrissa McFarlane, Chief Executive Officer, Patientory

Dr. Eric Topol, Founder and Director, Scripps Translational Science Institute; Executive VP and Professor, Molecular Medicine, The Scripps Research Institute

Hal Wolf, President and CEO, Healthcare Information and Management Systems Society

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

GeorgeP, Dio, Stelios, GeorgeG and GeorgeK are working on the next best thing.

042

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:30 PM

A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN

 

Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors

Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media

 

Moderator:Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

025

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

10:45 AM

CLIMBING OUT OF LAST PLACE: WEST VIRGINIA AND WELL-BEING

West Virginia consistently ranks last out of the 50 U.S. states when it comes to well-being—with the state levels of obesity, poverty, unemployment, and opioid abuse at or near the worst in the nation. But a surprising ray of hope is on the horizon—a new clinical program designed to help the Mountain State address these issues in a radical way. We offer an early look.

 

Dr. E. Gordon Gee, President, West Virginia University

Dr. Clay Marsh, Vice President and Executive Dean for Health Sciences, West Virginia University

Dr. Ali Rezai, Executive Chair, Vice President and Associate Dean, WVU Rockefeller Neuroscience Institute

 

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

037

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

2:25 PM

GUN VIOLENCE AS A PUBLIC HEALTH CRISIS

American students were once again caught in the crosshairs of a school massacre on Valentine’s Day—just after the country witnessed two of its deadliest mass shootings in a 35-day span. Parkland. Las Vegas. Sunderland. Newtown. The painful reminders that the U.S. is the world capital of gun violence keep piling up. Compounding this continuing sorrow is a bitter feud over how to stop it—a fight over firearms that has further polarized the nation. But some health experts say there’s a way to break through this deadly impasse: What if, instead of isolated acts of madness, we treated the ongoing casualties from guns as an epidemic? Here’s how reframing gun violence as an urgent matter of public health might at last lead us to a cure.

 

Dr. Dean Winslow, Professor of Medicine, Stanford University School of Medicine

Dr. Garen Wintemute, Director, Violence Prevention Research Program, UC Davis

Additional speakers to be announced.

Moderator: Michal Lev-Ram, Fortune

 

Photograph by Stuart Isett/Fortune

001

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

11:30 AM–1:00 PM

OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

 

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

 

Dr. Udit Batra, CEO, MilliporeSigma

David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit

Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute

Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

  

Photograph by Stuart Isett/Fortune

001

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

11:30 AM–1:00 PM

OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

 

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

 

Dr. Udit Batra, CEO, MilliporeSigma

David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit

Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute

Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

  

Photograph by Stuart Isett/Fortune

051

FORTUNE Brainstorm Tech 2023

Tuesday July 11th, 2023

Park City, Utah

USA

 

3:30–3:45 PM

FLY ME TO THE MOON

From robotics to climate tech, one of the world’s largest companies is still investing in pie-in-the-sky innovations. But so-called moonshots were hit hard by tech’s downturn, and a new mandate for greater efficiency across the industry. Is there still a place for big ideas in big tech?

 

Astro Teller, Captain of Moonshots (CEO), X

 

Photograph by Adam ONeill/Fortune

042

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:30 PM

A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN

 

Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors

Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media

 

Moderator:Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

042

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:30 PM

A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN

 

Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors

Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media

 

Moderator:Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

003

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:20 PM

U.S. HEALTH CARE: AT THE CROSSROADS

A whole lot has changed since Mark Bertolini, back in 2010, took the helm at Aetna, the (now) $63 billion health insurer: The Affordable Care Act, barely then a law, has launched and (kind of) death spiraled. Opioids have become an acknowledged public health enemy. Wellness has become a corporate mantra. Big data, AI, and blockchain, once mere Silicon Valley buzzwords, have become ways of business that health care companies cannot ignore. The whole system has consolidated, while a formidable crew of outsiders—Google, Apple, Amazon—appear poised to disrupt everything. Bertolini has been at the center of it all—in an intimate and candid conversation with Fortune Editor-in-Chief Clifton Leaf, he’ll talk about navigating one of the nation’s largest health insurers (and the 43rd-largest public company in America) through these waters, and about his final act—Aetna’s transformational deal with CVS—and what it means about the future of health care in America.

 

Mark Bertolini, Chairman and CEO, Aetna Inc.

Interviewer: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

003

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:20 PM

U.S. HEALTH CARE: AT THE CROSSROADS

A whole lot has changed since Mark Bertolini, back in 2010, took the helm at Aetna, the (now) $63 billion health insurer: The Affordable Care Act, barely then a law, has launched and (kind of) death spiraled. Opioids have become an acknowledged public health enemy. Wellness has become a corporate mantra. Big data, AI, and blockchain, once mere Silicon Valley buzzwords, have become ways of business that health care companies cannot ignore. The whole system has consolidated, while a formidable crew of outsiders—Google, Apple, Amazon—appear poised to disrupt everything. Bertolini has been at the center of it all—in an intimate and candid conversation with Fortune Editor-in-Chief Clifton Leaf, he’ll talk about navigating one of the nation’s largest health insurers (and the 43rd-largest public company in America) through these waters, and about his final act—Aetna’s transformational deal with CVS—and what it means about the future of health care in America.

 

Mark Bertolini, Chairman and CEO, Aetna Inc.

Interviewer: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

042

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:30 PM

A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN

 

Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors

Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media

 

Moderator:Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

031

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

12:30 PM

HOW TO CHANGE THE COURSE OF A DISEASE

It’s the last frontier: the human brain. When it comes to medical treatment, the brain and central nervous system remain the darkest, most forbidding, realm—even as our knowledge of how the brain and mind work grows by leaps each year. Now, some say we are at the edge of genuine breakthroughs in treatment for diseases that have haunted humankind for generations, from Huntington’s to ALS to Alzheimer’s. Two warriors on the front lines of brain science will share the latest discoveries and discuss what it will take to solve the most complex puzzles of our most complex organ.

Ann Romney, Global Ambassador, Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital

 

Dr. Rudolph Tanzi, Vice Chair of Neurology and Director, Genetics and Aging Research Unit, Massachusetts General Hospital; Professor of Neurology, Harvard Medical School

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

Brainstorm from @getgoglasgow in response to Irene Mcara Mcwilliams lecture

 

2 hours of work culminating in a result that designers shouldn't be brought in at the end, they should work alongside scientists, inventors and that the loop of invention is two ways.

 

Via Positive Psychology, authentic experiences, what is relaxation, finding our your true beliefs, the beatniks, questioning our futures and edward de bono's thinking hats!

 

sarahdrummond.wordpress.com

012

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:35 PM

THE NEXT BIG THING

When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.

 

Dr. Jessica Mega, Chief Medical Officer, Verily

Dr. Bryan Roberts, Partner, Venrock

Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune

 

Photograph by Stuart Isett/Fortune

Nemesea@Brainstorm festival 2012

002

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:05 PM

SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT

The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.

 

The Fortune Brainstorm Health Co-Chairs:

Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health

Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health

Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

035

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

1:00 PM

CONCURRENT LUNCH SOLUTION SESSIONS

PATIENT TRIALS WE CAN ACTUALLY LEARN FROM

Hosted by City of Hope

The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials—a process that has long been the intellectual and regulatory scaffold supporting the drug development enterprise, and one that has barely changed over the past seven decades. Despite all that expenditure—which ultimately helps push up the price of medicines—we still often know little about whether even approved drugs will work in any one individual and why. Luckily, there are a number of innovative ideas for evaluating the safety and efficacy of new medicines that may give us more information, more quickly—and maybe even more cheaply too. A no-holds-barred roundtable.

Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health

 

Matt de Silva, Co-Founder, CEO and Director, Notable Labs

Kathy Giusti, Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator

Dr. Linda Malkas, Professor and Associate Chair, Department of Molecular and Cellular Biology, City of Hope

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

Creative thinking and brainstorming day

 

031

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

12:30 PM

HOW TO CHANGE THE COURSE OF A DISEASE

It’s the last frontier: the human brain. When it comes to medical treatment, the brain and central nervous system remain the darkest, most forbidding, realm—even as our knowledge of how the brain and mind work grows by leaps each year. Now, some say we are at the edge of genuine breakthroughs in treatment for diseases that have haunted humankind for generations, from Huntington’s to ALS to Alzheimer’s. Two warriors on the front lines of brain science will share the latest discoveries and discuss what it will take to solve the most complex puzzles of our most complex organ.

Ann Romney, Global Ambassador, Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital

 

Dr. Rudolph Tanzi, Vice Chair of Neurology and Director, Genetics and Aging Research Unit, Massachusetts General Hospital; Professor of Neurology, Harvard Medical School

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

002

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:05 PM

SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT

The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.

 

The Fortune Brainstorm Health Co-Chairs:

Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health

Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health

Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

037

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

2:25 PM

GUN VIOLENCE AS A PUBLIC HEALTH CRISIS

American students were once again caught in the crosshairs of a school massacre on Valentine’s Day—just after the country witnessed two of its deadliest mass shootings in a 35-day span. Parkland. Las Vegas. Sunderland. Newtown. The painful reminders that the U.S. is the world capital of gun violence keep piling up. Compounding this continuing sorrow is a bitter feud over how to stop it—a fight over firearms that has further polarized the nation. But some health experts say there’s a way to break through this deadly impasse: What if, instead of isolated acts of madness, we treated the ongoing casualties from guns as an epidemic? Here’s how reframing gun violence as an urgent matter of public health might at last lead us to a cure.

 

Dr. Dean Winslow, Professor of Medicine, Stanford University School of Medicine

Dr. Garen Wintemute, Director, Violence Prevention Research Program, UC Davis

Additional speakers to be announced.

Moderator: Michal Lev-Ram, Fortune

 

Photograph by Stuart Isett/Fortune

012

FORTUNE Brainstorm Health 2019

April 2nd, 2019

San Diego, CA

 

5:13 PM

DATA THAT MAKES DOCTORS BETTER

A behind-the-curtain look at one A.I. technology that’s already transforming patient care. Israeli company Zebra Medical—which has FDA approval for heart disease detection—uses its A.I. algorithms to detect misdiagnosed diseases and early-stage cancers. Zebra’s CEO Eyal Gura shares how the technology catches medical issues, and how it doesn’t replace doctors but rather helps make them more efficient.

 

Eyal Gura, CEO and Chairman, Zebra Medical Vision

 

Photograph by Stuart Isett for Fortune

034

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

1:00 PM

CONCURRENT LUNCH SOLUTION SESSIONS

HEALTH CARE AND THE FOURTH INDUSTRIAL REVOLUTION

Hosted by Herman Miller

The industrial revolutions of yore heralded a transition from hand-powered production methods to machine-driven ones and the advent of mass production. The next industrial revolution is a decidedly digital one—and its implications for health care may be more significant than for any other industry. Far beyond telemedicine, the digital age isn’t just changing how we do medicine, but also how we define it. From the health gig economy to AI-run hospitals to on-demand diagnostics, technology is prompting a never-ending question: Where will this fourth revolution take us next?

 

Hema Budaraju, Product Lead, Health, Facebook

Sally Daub, CEO, Enlitic

Sajid Rahman, CEO, Telenor Health

Dr. Roy Schoenberg, President and CEO, American Well

Owen Tripp, Co-Founder and CEO, Grand Rounds

Moderator: Dr. David B. Agus, University of Southern California

Introduction: Mike O’Toole, Senior Vice President of Sales, Herman Miller

 

Photograph by Stuart Isett/Fortune

This is a brainstorm for another current project I am researching: Surrealism. (A3 Sketchbook, double page)

A guided brainstorming session led by Mary R. Wise.

004

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:45 PM

MENTAL HEALTH: THE MISSING LINK ON THE HEALTH CARE CONTINUUM

Mental health disorders are the leading cause of disability worldwide, and yet too often, we treat them as a separate domain from human health: We cut off the head from the body, as Kaiser Permanente CEO Bernard J. Tyson puts it. This separation isn’t just wrongheaded, say public health experts, it’s dangerous. An extraordinary conversation about changing that paradigm—from clinic to culture. How insights into depression, anxiety, and addiction can offer surprising clues to where the body breaks down, how to fix it….and, yes, how to talk about it.

 

Deborah DiSanzo, General Manager, IBM Watson Health

Amy Powell, President, Paramount Television and Digital Entertainment

Bernard J. Tyson, Chairman and CEO, Kaiser Permanente

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

For a top secret project.

I think some grandma's with their top secret grandchilds were spying on us...

 

Luckily we were talking in a coded language

For a top secret project.

I think some grandma's with their top secret grandchilds were spying on us...

 

Luckily we were talking in a coded language

Nemesea@Brainstorm festival 2012

042

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:30 PM

A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN

 

Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors

Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media

 

Moderator:Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

042

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:30 PM

A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN

 

Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors

Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media

 

Moderator:Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

Creative thinking and brainstorming day

Uploaded with the Flock Browser

021

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:30 AM

THE POWER OF BEDSIDE DATA

A technology that monitors a person’s respiratory rate, heart rate and movement may not seem, at first, like much of an innovation—but consider that EarlySense does this by way of a sensor slipped under your mattress. That allows staff at anywhere from hospitals to nursing homes keep an electronic eye on non-critical patients’ vital signs—in a way that doesn’t have to be invasive. Princess and the Pea: Meet the digital age.

 

Dr. Karissa Price-Rico, COO, EarlySense Ltd.

  

Photograph by Stuart Isett/Fortune

037

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

2:25 PM

GUN VIOLENCE AS A PUBLIC HEALTH CRISIS

American students were once again caught in the crosshairs of a school massacre on Valentine’s Day—just after the country witnessed two of its deadliest mass shootings in a 35-day span. Parkland. Las Vegas. Sunderland. Newtown. The painful reminders that the U.S. is the world capital of gun violence keep piling up. Compounding this continuing sorrow is a bitter feud over how to stop it—a fight over firearms that has further polarized the nation. But some health experts say there’s a way to break through this deadly impasse: What if, instead of isolated acts of madness, we treated the ongoing casualties from guns as an epidemic? Here’s how reframing gun violence as an urgent matter of public health might at last lead us to a cure.

 

Dr. Dean Winslow, Professor of Medicine, Stanford University School of Medicine

Dr. Garen Wintemute, Director, Violence Prevention Research Program, UC Davis

Additional speakers to be announced.

Moderator: Michal Lev-Ram, Fortune

 

Photograph by Stuart Isett/Fortune

1 2 ••• 54 55 57 59 60 ••• 79 80